Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysisPlain-Language Summary

Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysisPlain-Language Summary

Rationale & Objective: Focal segmental glomerulosclerosis (FSGS) is a rare condition that can lead to kidney function decline and chronic kidney failure. Immunosuppressants are used to treat primary FSGS. However, their efficacy and safety in FSGS are not clearly established. We assessed cur...

Full description

Bibliographic Details
Main Authors: Dawn J. Caster, Barbara Magalhaes, Natali Pennese, Andrea Zaffalon, Marina Faiella, Kirk N. Campbell, Jai Radhakrishnan, Vladmir Tesar, Howard Trachtman
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Kidney Medicine
Subjects:
Chronic kidney failure
end-stage kidney disease
end-stage renal disease
focal segmental glomerulosclerosis
immunosuppressive therapy
proteinuria
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059522001224

Internet

http://www.sciencedirect.com/science/article/pii/S2590059522001224

Similar Items